INFDIS

Pfizer CEO rules out generic COVID drug Paxlovid for China

by

Jan. 9 (Reuters) – Pfizer Inc (PFE.N) It’s not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, CEO Albert Bourla said Monday, but it is in discussions about the price of the branded product. Reuters reported on Friday that China is in talks with Pfizer … Read more

Asian stocks weigh China risks, and the yen hit a 6-month high

by

https://tmsnrt.rs/2zpUAr4 Asian markets recovered early losses, and US stock futures were flat The dollar broke below the 130 yen support level to reach a 6-month low Global growth fears are weighing on oil prices, but gold is rallying SYDNEY (Reuters) – Asian stocks recovered from early losses on Tuesday as investors weighed the near-term costs … Read more